Axelle Caudrillier

Axelle Caudrillier has a wealth of experience in genomics testing and operations management. Axelle began their career in 2006 as a Ph.D. student at Université de Picardie Jules Verne. In 2010, they moved to the United States to become a Postdoctoral Researcher at the University of California, San Francisco, specializing in lung diseases and acute inflammation. In 2014, they joined The University of Edinburgh as a Senior Scientist, where they managed and oversaw several projects related to inflammatory pulmonary and vascular diseases. In 2019, they took on the role of QC Supervisor at TC BioPharm Limited, developing a platform lab for PCR and Elisa assays to test efficiency of lentivirus based cell therapy. In 2020, they became Operations Manager and Senior Team Leader at Eurofins Biomnis, and Head of Platform Biology at Asklepios BioPharmaceutical, Inc. (AskBio). Her current role is Genomics Testing Operations Coordinator at Sano Genetics, which they began in 2022.

Axelle Caudrillier received their Master's degree from Université Paul Sabatier Toulouse III in 2006, majoring in Biology and Pharmacology. Axelle then went on to receive their Ph.D in Biology from Université de Picardie Jules Verne (Amiens) in 2009, specializing in Molecular and Cellular Biology.